Literature DB >> 7967351

Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury.

J L Simons1, A P Provoost, S Anderson, H G Rennke, J L Troy, B M Brenner.   

Abstract

The fawn-hooded rat constitutes a spontaneous model for chronic renal failure with early systemic and glomerular hypertension, proteinuria (UpV) and high susceptibility to development of focal and segmental glomerular sclerosis (FGS). It has been argued that uninephrectomy (UNX) accelerates the development of glomerular injury by aggravation of glomerular hypertension and by an independent effect to promote glomerular enlargement. The present study was performed to further delineate the importance of these parameters for the development of FGS. At the age of eight weeks male rats were UNX and randomly assigned to either control (CON), enalapril (ENA) or Nw-nitro L-arginine methyl ester (NAME) treatment. In all groups glomerular hemodynamic studies were performed four weeks post-UNX. Systemic blood pressure and UpV were monitored for 4 to 12 weeks post-UNX. Kidneys were then prepared for morphologic study. ENA treatment achieved control of both systemic and glomerular hypertension, maintenance of glomerular hyperfiltration and hyperperfusion, increased ultrafiltration coefficient(Kf), and long-term protection against UpV and FGS. NAME rats showed aggravation of both systemic and glomerular hypertension, decreased renal perfusion and filtration with reduced Kf, and high filtration fraction. The incidence of FGS in NAME and CON groups was similar at 8 and 12 weeks post-UNX, respectively. Glomerular enlargement was present in CON and ENA rats, but did not correlate with injury, while glomerular tuft size was lowest in NAME rats, which displayed prominent glomerular injury. Systemic blood pressure correlated strongly with glomerular capillary pressure. We conclude that systemic and glomerular hypertension govern the development of UpV and FGS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967351     DOI: 10.1038/ki.1994.287

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

Review 2.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

3.  Quantitative ultrastructural study of afferent and efferent arterioles in IgA glomerulonephritis and benign nephrosclerosis.

Authors:  Z Rázga; B Iványi; N Zidar; D Ferluga; S Sonkodi; J Ormos
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

4.  Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.

Authors:  John M Atkinson; Nick Pullen; Michelle Da Silva-Lodge; Lynne Williams; Tim S Johnson
Journal:  J Am Soc Nephrol       Date:  2014-11-19       Impact factor: 10.121

5.  Impaired renal hemodynamics and glomerular hyperfiltration contribute to hypertension-induced renal injury.

Authors:  Letao Fan; Wenjun Gao; Bond V Nguyen; Joshua R Jefferson; Yedan Liu; Fan Fan; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-24

6.  Decreased alpha-adrenergic constriction of renal preglomerular arteries occurs with age and is gender-specific in the rat.

Authors:  Jeff C Falcone; Irving G Joshua; John C Passmore
Journal:  Age (Dordr)       Date:  2005-12-10

7.  Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

Authors:  Laura G Sánchez-Lozada; Virgilia Soto; Edilia Tapia; Carmen Avila-Casado; Yuri Y Sautin; Takahiko Nakagawa; Martha Franco; Bernardo Rodríguez-Iturbe; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13

8.  Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data.

Authors:  K Melissa Hallow; Peter J Greasley; Gabriel Helmlinger; Lulu Chu; Hiddo J Heerspink; David W Boulton
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-18

9.  Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.

Authors:  Jan Michael Williams; Mukut Sharma; Siddam Anjaiahh; John R Falck; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2007-05-16

10.  Glomerular hypertrophy after subtotal nephrectomy: relationship to early glomerular injury.

Authors:  S Tenschert; M Elger; K V Lemley
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.